These clinical indicators, which were statistically different between 0 to W4, and between 0 and W8, are markers of endothelial dysfunction associated with diabetes and thrombosis, indicating that GLP-1 has a good hypoglycemic effect on type 2 diabetic patients and a protective effect on vascular endothelial function. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.